Advertisements


Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results

LIVONIA, Mich., March 15, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a serious.....»»

Category: earningsSource: benzingaMar 15th, 2019

Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018 and Operational Progress

Conference Call Today at 1:00pm BST / 8:00am EDT OXFORD, United Kingdom and CAMBRIDGE, Mass.,.....»»

Category: earningsSource: benzingaApr 11th, 2018

Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results.....»»

Category: earningsSource: benzinga56 min. ago

MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results

MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results.....»»

Category: earningsSource: benzinga56 min. ago

Destination XL Group, Inc. Reports Fiscal 2018 Fourth-Quarter and Full Year Financial Results

CANTON, Mass., March 22, 2019 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ:DXLG), the largest omni-channel spe.....»»

Category: earningsSource: benzingaMar 22nd, 2019

Glance Technologies Reports Financial Year 2018 Results

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Glance Technologies Inc. (CSE:GET, OTCQB:GLNNF) ("Glance" or the "Company") ​today announced financial results for the fourth quarter and fiscal year ended November 30, 20.....»»

Category: earningsSource: benzingaMar 21st, 2019

Lazydays Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Lazydays Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results.....»»

Category: earningsSource: benzingaMar 21st, 2019

DSW Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results

DSW Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results.....»»

Category: earningsSource: benzingaMar 19th, 2019

X Financial Reports Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results

SHENZHEN, China, March 18, 2019 /PRNewswire/ -- X Financial (NYSE:XYF) (the "Company" or "we"), a leading technology-driven personal finance company in Chin.....»»

Category: earningsSource: benzingaMar 18th, 2019

Amyris Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Announces Signing of $300 Million Definitive Cannabinoid Agreement

Amyris Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Announces Signing of $300 Million Definitive Cannabinoid Agreement.....»»

Category: earningsSource: benzingaMar 18th, 2019

Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results.....»»

Category: earningsSource: benzingaMar 18th, 2019

Phoenix New Media Reports Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results

Phoenix New Media Reports Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results.....»»

Category: earningsSource: benzingaMar 18th, 2019

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results

CANTON, Mass. , March 18, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the developme.....»»

Category: earningsSource: benzingaMar 18th, 2019

StoneCo Reports Fourth Quarter and Fiscal Year 2018 Financial Results

SÃO PAULO, Brazil, March 18, 2019 (GLOBE NEWSWIRE) -- StoneCo Ltd. (NASDAQ:STNE) ("Stone" or the "Company"), a leading provider of financial technology solutions that .....»»

Category: earningsSource: benzingaMar 18th, 2019

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results

REDWOOD CITY, Cali.....»»

Category: earningsSource: benzingaMar 18th, 2019

Regulus Reports Fourth Quarter and Year-End 2018 Financial Results and Recent Updates

LA JOLLA, Calif., March 18, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company focused on the discovery and devel.....»»

Category: earningsSource: benzingaMar 18th, 2019

Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

Company achieves FY 2018 total net revenues of $130.4 million  FY 2018.....»»

Category: earningsSource: benzingaMar 14th, 2019

Axsome Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Company to host conference call today at 8:00 AM Eastern NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developin.....»»

Category: earningsSource: benzingaMar 14th, 2019

Neos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results

- New commercial strategy including optimized salesforce structure, new distribution network and focus on improving net margins expected to accelerate pa.....»»

Category: earningsSource: benzingaMar 14th, 2019

Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights

Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights.....»»

Category: earningsSource: benzingaMar 14th, 2019

GreenTree Hospitality Group Ltd. Reports Fourth Quarter and Fiscal Year 2018 Financial Results

GreenTree Hospitality Group Ltd. Reports Fourth Quarter and Fiscal Year 2018 Financial Results.....»»

Category: earningsSource: benzingaMar 14th, 2019